发明名称 Pharmaceuticals for Oral Delivery
摘要 The present invention provides pharmaceutical compositions suitable for oral delivery and methods of treating subjects in need thereof. The pharmaceutical compositions of the present invention enhance bioavailability of at least one compound classified as BCS Class II, BCS Class III or BCS Class IV.
申请公布号 US2017056328(A1) 申请公布日期 2017.03.02
申请号 US201615353213 申请日期 2016.11.16
申请人 Enteris BioPharma, Inc. 发明人 Carl Stephen M.;Vrettos John Stanley;Stern William
分类号 A61K9/48;A61K31/7036;A61K31/351;A61K9/00;A61K31/65 主分类号 A61K9/48
代理机构 代理人
主权项 1. A solid oral dosage form comprising: a mixture comprising: a therapeutically effective amount of at least one active pharmaceutical compound classified as BCS Class III, wherein the compound does not include a peptide bond in the molecular structure of the compound;an absorption enhancer; andfrom 100 mg to 500 mg of coated citric acid particles, wherein the citric acid particles are coated with a water soluble coat that separates the citric acid from the active pharmaceutical compound, wherein, if the dosage form was added to ten milliliters of 0.1 M aqueous sodium bicarbonate solution, the pH of the solution would be acidified to a pH no higher than 5.5; an enteric coating; and a water soluble barrier positioned between the mixture and the enteric coating, thereby separating the mixture from the enteric coating, wherein oral administration results in a synergistic increase in systemic bioavailability of the active pharmaceutical compound when compared to the systemic bioavailability provided by administration of a solid dosage form containing an equal dose of the active pharmaceutical compound without the absorption enhancer and the citric acid.
地址 Boonton NJ US
您可能感兴趣的专利